XML 50 R40.htm IDEA: XBRL DOCUMENT v3.25.3
Product Acquisitions and Return of Product Rights - Narrative (Details) - USD ($)
 1 Months Ended 9 Months Ended
Feb. 05, 2025
Jan. 03, 2022
Oct. 31, 2023
Jan. 31, 2023
Apr. 30, 2019
Nov. 30, 2018
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Business Combination [Line Items]                  
Net investment in manufacturing             $ 1,447,695 $ 0  
Product Assets And Global Rights - Vibativ                  
Business Combination [Line Items]                  
Net investment in manufacturing           $ 20,000,000      
Milestone payment         $ 5,000,000        
Tiered royalty payments, threshold           $ 3,000,000      
Additional liability             3,562,667   $ 3,242,999
Current portion of accrued contingent consideration             1,700,000    
Non-current portion of accrued contingent consideration             1,900,000    
Product Assets And Global Rights - Vibativ | Maximum                  
Business Combination [Line Items]                  
Tiered royalty payments (percentage)           20.00%      
U.S. Product Asset Rights - Sancuso                  
Business Combination [Line Items]                  
Net investment in manufacturing   $ 13,500,000              
Milestone payment     $ 500,000 $ 1,000,000          
Tiered royalty payments, threshold   $ 3,500,000              
Additional liability             1,275,000   $ 1,516,000
Current portion of accrued contingent consideration             700,000    
Non-current portion of accrued contingent consideration             600,000    
Milestone payment remaining             $ 2,000,000.0    
U.S. Product Asset Rights - Sancuso | Maximum                  
Business Combination [Line Items]                  
Tiered royalty payments (percentage) 5.00% 10.00%